We aim to design novel platforms for a selective delivery of therapeutic payload to specific target cells, thus increasing the efficiency and reducing adverse effects.
Menu
972-3-640-7925
We aim to design novel platforms for a selective delivery of therapeutic payload to specific target cells, thus increasing the efficiency and reducing adverse effects.
This research aims to broaden the nanotechnology toolbox by designing new, highly efficient, methodologies for nucleic acids delivery.
LeukoTheranostics – Harnessing targeted nanotheranostics to reprogram activated leukocytes in inflammatory bowel disease
Mailing Address: Department of Cell Research and Immunology, Tel-Aviv University, Ramat Aviv, Tel-Aviv, 69978 Israel
Office Address: Britannia Building, office 226 Tel: 972-3-640-5926 Fax: 972-3-640-5926
Labs:
(1) Britannia Building, room 226
(2) Center of Nanotechnology and Nanoscience, room 27
Tel: 972-3-640-7925 (Britannia lab)
Tel: 972-3-640-5600 (Nano lab)
Mailing Address: Department of Cell Research and Immunology, Tel-Aviv University, Ramat Aviv, Tel-Aviv, 69978 Israel
Office Address: Britannia Building, office 226 Tel: 972-3-640-5926 Fax: 972-3-640-5926
Labs:
(1) Britannia Building, room 226
(2) Center of Nanotechnology and Nanoscience, room 27
Tel: 972-3-640-7925 (Britannia lab)
Tel: 972-3-640-5600 (Nano lab)